Nox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Aging is associated with cerebrovascular dysregulation, which may underlie the increased susceptibility to ischemic stroke and vascular cognitive impairment occurring in the elder individuals. Although it has long been known that oxidative stress is responsible for the cerebrovascular dysfunction, the enzymatic system(s) generating the reactive oxygen species (ROS) have not been identified. In this study, we investigated whether the superoxide-producing enzyme NADPH oxidase is involved in alterations of neurovascular regulation induced by aging. Cerebral blood flow (CBF) was recorded by laser-Doppler flowmetry in anesthetized C57BL/6 mice equipped with a cranial window (age = 3, 12, and 24 months). In 12-month-old mice, the CBF increases evoked by whisker stimulation or by the endothelium-dependent vasodilators acetylcholine and bradykinin were attenuated by 42, 36, and 53%, respectively ( P < 0.05). In contrast, responses to the nitric oxide donor S-nitroso-D-penicillamine or adenosine were not attenuated ( P > 0.05). These cerebrovascular effects were associated with increased production of ROS in neurons and cerebral blood vessels, assessed by hydroethidine microfluorography. The cerebrovascular impairment present in 12-month-old mice was reversed by the ROS scavenger Mn (III) tetrakis (4-benzoic acid) porphyrin chloride or by the NADPH oxidase peptide inhibitor gp91ds-tat, and was not observed in mice lacking the Nox2 subunit of NADPH oxidase. These findings establish Nox2 as a critical source of the neurovascular oxidative stress mediating the deleterious cerebrovascular effects associated with increasing age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental studies suggest that radicals produced by the enzyme nicotinamide adenine dinucleotide phosphate oxidase are responsible for the cerebrovascular alterations induced by VCI risk factors and Aβ.112,122–124”
In the citing paper
“In animal models, the major risk factors for VCI and Alzheimer disease —hypertension, aging, and diabetes110—impair endothelium-dependent responses in the cerebral microcirculation and blunt functional hyper-emia.101,111,112”
In the citing paper
“Thus, functional hyperemia and endothelium dependent responses are attenuated in models of aging, hypertension, and diabetes (Ergul, 2011; Kazama et al., 2004; Park et al., 2007), whereas the ability of the vessels to adjust cerebral perfusion in response to changes in blood pressure (autoregulation) is blunted in patients with diabetes or hypertension (Kim et al., 2008b; Novak et al., 2003).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Park et al., 2007
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 5×
“The catalytic subunit of the enzyme gp91phox, also termed ‘Nox2,’ is present in several homologs (Nox1 through Nox5) (Bedard and Krause, 2007).”
BackgroundInfluentialMitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 1×
“Aging is associated with increased ROS production in brain and other organs (Balaban et al, 2005).”
BackgroundNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · cited 1×
“However, less is known about the effects of aging on the increase in CBF induced by synaptic activity, a critical homeostatic response that matches the energetic needs of the active brain with the delivery of nutrients through blood flow (Iadecola, 2004).”
BackgroundSelf-citationCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · cited 7×
“…(2007) 27, 1908–1918 & 2007 ISCBFM All rights reserved 0271-678X/07 $30.00 www.jcbfm.com mediated by oxidative stress, but the cellular sources of reactive oxygen species (ROS) and the enzymatic systems generating them have not been defined (Faraci and Heistad, 1998; Farkas and Luiten, 2001).”
BackgroundInfluentialRothwell, P., Coull, A., Silver, L., Fairhead, J., Giles, M., Lovelock, C., Redgrave, J., Bull, L., Welch, S., Cuthbertson, F., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67702-1 · Cited by 967 · cited 1×
“Aging has profound cerebrovascular effects that are thought to underlie the increased incidence of ischemic stroke and vascular cognitive impairment affecting older individuals (Farkas and Luiten, 2001; Rothwell et al, 2005).”
BackgroundPollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921 · cited 1×
“Nox2deficient mice (Pollock et al, 1995) were obtained from our own colony and were congenic with the C57BL/6 strain (Park et al, 2005).”
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780 · cited 9×
“…(2007) 27, 1908–1918 & 2007 ISCBFM All rights reserved 0271-678X/07 $30.00 www.jcbfm.com mediated by oxidative stress, but the cellular sources of reactive oxygen species (ROS) and the enzymatic systems generating them have not been defined (Faraci and Heistad, 1998; Farkas and Luiten, 2001).”
BackgroundInfluentialEnhanced Peroxynitrite Formation Is Associated with Vascular Aging
van der Loo, B., Labugger, R., Skepper, J. N., Bachschmid, M., Kilo, J., Powell, J. M., Palacios-Callender, M., Erusalimsky, J. D., Quaschning, T., Malinski, T., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1731 · Cited by 675 · cited 1×
“However, in the case of acetylcholine, a reduction in the synthesis and/or bioavailability of nitric oxide could also play a role (van der Loo et al, 2000).”
BackgroundRey, F. E., Cifuentes, M. E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 605 · cited 2×
“In these experiments, we used the NADPH oxidase peptide inhibitor gp91ds-tat (Kazama et al, 2004; Park et al, 2005; Rey et al, 2001) to establish whether the age-related alterations in neurovascular function are mediated by NADPH oxidase.”
MethodAging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function
Csiszar, A., Ungvari, Z., Edwards, J. G., Kaminski, P., Wolin, M. S., Koller, A., & Kaley, G. (2002) · Circulation Research · doi:10.1161/01.res.0000020401.61826.ea · Cited by 563 · cited 2×
“Some reports have described an increase in NADPH oxidase subunits in systemic blood vessels (Adler et al, 2003; Hamilton et al, 2001; Oudot et al, 2006), whereas others have not (Bachschmid et al, 2004; Csiszar et al, 2002; Newaz et al, 2006).”
Background
Research works printed but not linked: 4
- 10.1016/s0008-6363(96)00136-8 · doi:10.1016/s0008-6363(96)00136-8 · Paper page
- Iadecola C, 1992, Am J Physiol, 263, R1156
- Mayhan WG, 1990, Am J Physiol, 258, H1138
- Savolainen H, 1978, Res Commun Chem Pathol Pharmacol, 21, 173
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationThe Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…hyperemia and endothelium dependent responses are attenuated in models of aging, hypertension, and diabetes (Ergul, 2011; Kazama et al., 2004; Park et al., 2007), whereas the ability of the vessels to adjust cerebral perfusion in response to changes in blood pressure (autoregulation) is…”
Self-citationHallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242
Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B., & Faraci, F. M. (2021) · Physiological Reviews · doi:10.1152/physrev.00022.2020 · Cited by 915
Ungvari, Z., Tarantini, S., Donato, A. J., Galvan, V., & Csiszar, A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311378 · Cited by 919
“There is strong evidence that endothelial dysfunction caused by increased oxidative stress contributes significantly to both impaired dilation of coronary arteries,(13) promoting myocardial ischemia, and neurovascular uncoupling, impairing the moment-to-moment adjustment of cerebral blood flow to increased oxygen and…”
BackgroundWhy neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Melatonin—A pleiotropic, orchestrating regulator molecule
Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843
“Moreover, melatonin inhibits the LPS-induced expression of various CC chemokines in peripheral blood mononuclear cells (H.J. Park et al., 2007).”
BackgroundMechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease
Donato, A. J., Machin, D. R., & Lesniewski, L. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312563 · Cited by 688
Hypertension and Cerebrovascular Dysfunction
Iadecola, C., & Davisson, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.010 · Cited by 557
“The CBF reductions are likely to result from a combination of factors, including aging, reduced brain activity, vascular narrowing, as well as increased vascular tone secondary to endothelial dysfunction (Barry, 1985; Mentis et al., 1994; Park et al., 2007).”
BackgroundSelf-citationThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
“Animal and human studies indicate that risk factors for VCI and AD, such as hypertension, aging, dyslipidemia, and diabetes, have profound effects on cerebrovascular regulation, and disrupt endothelium-dependent vasodilatation, functional hyperemia, and autoregulation [42, 53, 60, 66, 73, 80, 91].”
Self-citationHypertension-induced cognitive impairment: From pathophysiology to public health
Ungvari, Z., Toth, P., Tarantini, S., Prodan, C. I., Sorond, F., Merkely, B., & Csiszar, A. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00430-6 · Cited by 544
Toth, P., Tarantini, S., Csiszar, A., & Ungvari, Z. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2016 · Cited by 522
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
“These indications include age-dependent neurovascular de-regulation (131), AngII-induced de-regulations in cerebral blood flow, and neurovascular coupling (59, 84), as well as Alzheimer’s disease models, namely in amyloid precursor protein- (133) and amyloid beta peptideinduced de-regulations (132).”
BackgroundAstrocytes and the regulation of cerebral blood flow
Koehler, R. C., Roman, R. J., & Harder, D. R. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.005 · Cited by 444
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z., & Csiszar, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.004 · Cited by 411
“For example, previous studies showed that acute inhibition of NADPH oxidases (Park et al. 2007) and/or mitochondria-derived production of reactive oxygen species (ROS)(Toth et al. 2014) in aged mice is able to significantly improve microvascular endothelial function and improve neurovascular…”
BackgroundInfluentialCerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Toda, N., Ayajiki, K., & Okamura, T. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000547 · Cited by 386
“…or by ACh and BK was attenuated in association with increased ROS production in neurons and cerebral blood vessels; the cerebrovascular impairment was reversed by a ROS scavenger or by gp91 ds/tat, and it was not observed in mice lacking the NOX-2 subunit of NAD(P)H oxidase (Park et al., 2007).”
BackgroundPericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss
Nikolakopoulou, A. M., Montagne, A., Kisler, K., Dai, Z., Wang, Y., Huuskonen, M. T., Sagare, A. P., Lazic, D., Sweeney, M. D., Kong, P., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0434-z · Cited by 391
“CBF response to 400 μm adenosine applied through an open cranial window was measured using laser-Doppler flowmetry (LDF) in mice under 1% isoflurane anesthetic as described 13,68,69 .”
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
Park, L., Zhou, P., Pitstick, R., Capone, C., Anrather, J., Norris, E. H., Younkin, L., Younkin, S., Carlson, G., McEwen, B. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711568105 · Cited by 332
“Considering that aging attenuates CBF responses also in WT mice via Nox2-derived ROS (31), it is more likely that aging and the associated increase in brain A levels acted in concert to enhance oxidative stress and the vascular dysfunction.”
BackgroundSelf-citationTarantini, S., Valcarcel-Ares, M. N., Toth, P., Yabluchanskiy, A., Tucsek, Z., Kiss, T., Hertelendy, P., Kinter, M., Ballabh, P., Süle, Z., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101192 · Cited by 282
“formation, suggesting that impaired endothelial mediation of cerebromicrovascular dilation in aging is due to increased scavenging of vasodilator NO [9].”
BackgroundNox2 redox signaling maintains essential cell populations in the brain
Dickinson, B. C., Peltier, J., Stone, D., Schaffer, D. V., & Chang, C. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.497 · Cited by 273
Experimental models of vascular dementia and vascular cognitive impairment: a systematic review
Jiwa, N. S., Garrard, P., & Hainsworth, A. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06958.x · Cited by 254
“These are evident in rats and mice from age 12 months (Goldman et al. 1992; Park et al. 2007; Storozheva et al. 2008).”
BackgroundHypertension, Brain Damage and Cognitive Decline
Gąsecki, D., Kwarciany, M., Nyka, W., & Narkiewicz, K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0398-4 · Cited by 211
Age-related changes in endothelial function and blood flow regulation
Toda, N. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.004 · Cited by 212
The role of oxidative stress and NADPH oxidase in cerebrovascular disease
Chrissobolis, S., & Faraci, F. M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.003 · Cited by 211
Oxidative stress and endothelial dysfunction in cerebrovascular disease
Chrissobolis, S. (2011) · Frontiers in Bioscience · doi:10.2741/3816 · Cited by 204
Threats to the Mind: Aging, Amyloid, and Hypertension
Iadecola, C., Park, L., & Capone, C. (2009) · Stroke · doi:10.1161/strokeaha.108.533638 · Cited by 207
Self-citationToth, P., Tarantini, S., Tucsek, Z., Ashpole, N. M., Sosnowska, D., Gautam, T., Ballabh, P., Koller, A., Sonntag, W. E., Csiszar, A., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00744.2013 · Cited by 200
Protecting against vascular disease in brain
Faraci, F. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01310.2010 · Cited by 196
COPD and stroke: are systemic inflammation and oxidative stress the missing links?
Austin, V., Crack, P. J., Bozinovski, S., Miller, A. A., & Vlahos, R. (2016) · Clinical Science · doi:10.1042/cs20160043 · Cited by 190
Tarantini, S., Valcarcel‐Ares, N. M., Yabluchanskiy, A., Fulop, G. A., Hertelendy, P., Gautam, T., Farkas, E., Perz, A., Rabinovitch, P. S., Sonntag, W. E., et al. (2018) · Aging Cell · doi:10.1111/acel.12731 · Cited by 191
“Accordingly, in the cerebral circulation of aged mice increased mitochondrial oxidative stress is associated with an upregulated expression and activity of NADPH oxidases (Park et al., 2007; Toth et al., 2014), which appear to be partially reversed by SS-31 (Figure 2i) as well as by other interventions that attenuate…”
BackgroundInfluentialMolecular and cellular pathways contributing to brain aging
Zia, A., Pourbagher-Shahri, A. M., Farkhondeh, T., & Samarghandian, S. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00179-9 · Cited by 181
Neurovascular Dysfunction in Vascular Dementia, Alzheimer's and Atherosclerosis
Shabir, O., Berwick, J., & Francis, S. E. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0465-5 · Cited by 191
Tucsek, Z., Toth, P., Tarantini, S., Sosnowska, D., Gautam, T., Warrington, J. P., Giles, C. B., Wren, J. D., Koller, A., Ballabh, P., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu080 · Cited by 191
Carvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 177
Iron Toxicity in Mice with Collagenase-Induced Intracerebral Hemorrhage
Wu, H., Wu, T., Xu, X., Wang, J., & Wang, J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.209 · Cited by 180
Zimmerman, B., Rypma, B., Gratton, G., & Fabiani, M. (2021) · Psychophysiology · doi:10.1111/psyp.13796 · Cited by 179
Microvascular Dysfunction and Cognitive Impairment
De Silva, T. M., & Faraci, F. M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0308-1 · Cited by 171
“As the endothelial component of microvascular disease progresses (Li et al. 2013; Mayhan et al. 2008; Modrick et al. 2009; Park et al. 2007; Shi et al. 2014; Walker et al. 2014), the process impacts other cell types in the vessel wall.”
BackgroundAstrocytic metabolic and inflammatory changes as a function of age
Jiang, T., & Cadenas, E. (2014) · Aging Cell · doi:10.1111/acel.12268 · Cited by 158
“contributes to chronic inflammation in aging and various neurodegenerative disorders (Park et al., 2007).”
BackgroundCsiszar, A., Gautam, T., Sosnowska, D., Tarantini, S., Banki, E., Tucsek, Z., Toth, P., Losonczy, G., Koller, A., Reglodi, D., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00307.2014 · Cited by 160
Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
Wang, F., Cao, Y., Ma, L., Pei, H., Rausch, W. D., & Li, H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00376 · Cited by 157
“Antioxidants or blockade of NOX-2 can result in the improvement of CEC and NVC function (Erdos et al., 2006; Park et al., 2007, 2017; Judkins et al., 2010; Ma et al., 2017; Qin et al., 2017).”
BackgroundPark, L., Wang, G., Zhou, P., Zhou, J., Pitstick, R., Previti, M. L., Younkin, L., Younkin, S. G., Van Nostrand, W. E., Cho, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015413108 · Cited by 156
“CBF responses to adenosine (400 μM; Sigma) or hypercapnia (PCO2, 50–60 mmHg) were also tested (22, 35).”
MethodSelf-citationRole of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
IGF‐1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging
Toth, P., Tarantini, S., Ashpole, N. M., Tucsek, Z., Milne, G. L., Valcarcel‐Ares, N. M., Menyhart, A., Farkas, E., Sonntag, W. E., Csiszar, A., et al. (2015) · Aging Cell · doi:10.1111/acel.12372 · Cited by 153
“, 2007), mimicking the aging phenotype (Park et al., 2007; Toth et al., 2014a).”
BackgroundInfluentialFree radical biology of the cardiovascular system
Chen, A. F., Chen, D.-D., Daiber, A., Faraci, F. M., Li, H., Rembold, C. M., & Laher, I. (2012) · Clinical Science · doi:10.1042/cs20110562 · Cited by 152
Vascular Aspects of Cognitive Impairment and Dementia
Wiesmann, M., Kiliaan, A. J., & Claassen, J. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.159 · Cited by 143
Involvement of NADPH oxidase in age-associated cardiac remodeling
Wang, M., Zhang, J., Walker, S. J., Dworakowski, R., Lakatta, E. G., & Shah, A. M. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.006 · Cited by 150
“been implicated in age-related vascular endothelial dysfunction [27,28].”
BackgroundNeurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer’s disease
Zhu, W. M., Neuhaus, A., Beard, D. J., Sutherland, B. A., & DeLuca, G. C. (2022) · Brain · doi:10.1093/brain/awac174 · Cited by 133
“tration by ROS (forming peroxynitrites, a mediator of nitrosative stress).(135) Katusic and Austin make the point that increased ROS are a feature of Alzheimer’s disease as well as the cardiovascular diseases that are risk factors for Alzheimer’s disease;(136) thus, it is conceivable that this oxidative environment re…”
BackgroundPharmacologically-Induced Neurovascular Uncoupling is Associated with Cognitive Impairment in Mice
Tarantini, S., Hertelendy, P., Tucsek, Z., Valcarcel-Ares, M. N., Smith, N., Menyhart, A., Farkas, E., Hodges, E. L., Towner, R., Deak, F., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.162 · Cited by 144
Giffard, R. G., Han, R., Emery, J. F., Duan, M., & Pittet, J. (2008) · Anesthesiology · doi:10.1097/aln.0b013e31817f4ce0 · Cited by 170
“That neuronal NADPH oxidase plays a role in aging and hypoglycemic injury was also suggested.(122,123) Heat shock induction of Hsp72 reduces NADPH oxidase activity in neutrophils and increases superoxide dismutase, which scavenges superoxide, in phagocytes.”
BackgroundInsulin-like growth factor-1 in CNS and cerebrovascular aging
Sonntag, W. E., Deak, F., Ashpole, N., Toth, P., Csiszar, A., Freeman, W., & Ungvari, Z. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00027 · Cited by 136
“Age-related oxidative stress impairs the bioavailability of NO, which is responsible, at least in part, for impairment of cerebromicrovascular function (Park et al., 2007) and may contribute to microvascular rarefaction.”
BackgroundInfluentialNADPH oxidases as therapeutic targets in ischemic stroke
Kahles, T., & Brandes, R. P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1011-8 · Cited by 150
“Many animal models of neurological diseases with involvement of the cerebral vasculature, such as Alzheimer’s disease [52–54] or ischemic stroke (reviewed by [55]), as well as models of stroke-related risk factors [56–58] have shown a diseaseassociated increase in ROS formation and signs of attenuated endothelial func…”
BackgroundNeurovascular Coupling in Development and Disease: Focus on Astrocytes
Stackhouse, T. L., & Mishra, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702832 · Cited by 125
The neurovascular unit and combination treatment strategies for stroke
Zhang, L., Zhang, Z. G., & Chopp, M. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.006 · Cited by 145
Yang, Q., Huang, Q., Hu, Z., & Tang, X. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01036 · Cited by 137
Cholesterol in Alzheimers Disease: Unresolved Questions
Stefani, M., & Liguri, G. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313899 · Cited by 133
The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention
Xu, H., Wang, Z., Li, J., Wu, H., Peng, Y., Fan, L., Chen, J., Gu, C., Yan, F., Wang, L., et al. (2017) · Neural Plasticity · doi:10.1155/2017/5405104 · Cited by 128
“The neuroprotective effect of gp91ds-tat was first discovered in cerebrovascular dysregulation associated with increasing age [96, 97].”
BackgroundInnate immunity receptor CD36 promotes cerebral amyloid angiopathy
Park, L., Zhou, J., Zhou, P., Pistick, R., El Jamal, S., Younkin, L., Pierce, J., Arreguin, A., Anrather, J., Younkin, S. G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300021110 · Cited by 130
“S1), implicating CD36 in the cerebrovascular alterations induced by aging (26).”
BackgroundSelf-citationHan, B. H., Zhou, M.-L., Johnson, A. W., Singh, I., Liao, F., Vellimana, A. K., Nelson, J. W., Milner, E., Cirrito, J. R., Basak, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414930112 · Cited by 131
“Importantly, the latter studies did not examine for the presence of CAA, nor did they assess for the effect of CAA on cerebral arteriole function (28, 35).”
InfluentialAge-Dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy
Park, L., Koizumi, K., El Jamal, S., Zhou, P., Previti, M. L., Van Nostrand, W. E., Carlson, G., & Iadecola, C. (2014) · Stroke · doi:10.1161/strokeaha.114.005179 · Cited by 128
Self-citationCauses and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Cruz Hernández, J. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 124
“These vascular changes are correlated with increased levels of reactive oxygen species (ROS) and vascular inflammation.(33,34) There is also an age-dependent decrease in capillary density.”
BackgroundSelf-citationContributions of Aging to Cerebral Small Vessel Disease
De Silva, T. M., & Faraci, F. M. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034338 · Cited by 122
“CBF responses to hypercapnia can become impaired with more advanced age, however (49, 52).”
BackgroundInfluentialImpact of ACE2 Deficiency and Oxidative Stress on Cerebrovascular Function With Aging
Silva, R. A. P., Chu, Y., Miller, J. D., Mitchell, I. J., Penninger, J. M., Faraci, F. M., & Heistad, D. D. (2012) · Stroke · doi:10.1161/strokeaha.112.667063 · Cited by 120
Obesity-induced cognitive impairment in older adults: a microvascular perspective
Balasubramanian, P., Kiss, T., Tarantini, S., Nyúl-Tóth, Á., Ahire, C., Yabluchanskiy, A., Csipo, T., Lipecz, A., Tabak, A., Institoris, A., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2020 · Cited by 115
Csipo, T., Mukli, P., Lipecz, A., Tarantini, S., Bahadli, D., Abdulhussein, O., Owens, C., Kiss, T., Balasubramanian, P., Nyúl-Tóth, Á., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00122-x · Cited by 112
“Among the microvascular mechanisms involved in the pathogenesis ofVCI, the importance of age-related impairment of a key cerebral homeostatic mechanism, neurovascular coupling (NVC), has received much attention in the past decade (Faraco et al. 2016; Girouard and Iadecola 2006; Gorelick et al. 2011; Hamel et al. 2016;…”
BackgroundInfluentialImplicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Graves, S. I., & Baker, D. J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13403 · Cited by 118
NADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 126
Inaba, S., Iwai, M., Furuno, M., Tomono, Y., Kanno, H., Senba, I., Okayama, H., Mogi, M., Higaki, J., & Horiuchi, M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123612 · Cited by 114
Death by a Thousand Cuts in Alzheimer’s Disease: Hypoxia—The Prodrome
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9379-2 · Cited by 122
“…hypoperfusion in OSA/ hypertension may be exacerbated by other factors, including aging and brain activity decrease (Barry 1985; Mentis et al. 1994; Mathiassen et al. 2007; Park et al. 2007; Foster et al. 2009; Chen et al. 2011a, b; Levy et al. 2012; González-Martín et al. 2009; Hakim et al. 2012).”
BackgroundAge‐Related Alterations in Reactivity of Cerebral Arterioles: Role of Oxidative Stress
Mayhan, W. G., Arrick, D. M., Sharpe, G. M., & Sun, H. (2008) · Microcirculation · doi:10.1080/10739680701641421 · Cited by 112
“Further, it has been reported that an increase in the activity of NAD(P)H oxidase may be an important source of oxidative stress during aging [4, 5, 37].”
BackgroundMethodInfluentialCahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 106
Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging
Modrick, M. L., Didion, S. P., Sigmund, C. D., & Faraci, F. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00300.2009 · Cited by 108
“While the present study was in progress, evidence that superoxide is produced by NADPH oxidase and contributes to cerebral vascular dysfunction with aging appeared (29, 34).”
BackgroundInfluentialBolduc, V., Thorin‐Trescases, N., & Thorin, É. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00624.2012 · Cited by 120
“NADPH-oxidase-derived ROS could account for the weakened CBF response to whisker stimulation, hypercapnia, and low endothelium-dependent vasodilation in old, healthy mice (186).”
BackgroundCerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 114
“CEREBRAL VASCULAR FUNCTION”
BackgroundInfluentialTarantini, S., Yabluchanskiy, A., Csípő, T., Fülöp, G. Á., Kiss, T., Balasubramanian, P., DelFavero, J., Ahire, C., Ungvari, A., Nyúl‐Tóth, Á., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00101-2 · Cited by 107
“1) (Park et al. 2007).”
Tarantini, S., Balasubramanian, P., DelFavero, J., Csípő, T., Yabluchanskiy, A., Kiss, T., Nyúl‐Tóth, Á., Mukli, P., Tóth, P., Ahire, C., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00440-z · Cited by 107
“Translational studies show that endothelial function is compromised in older adults [22] and aged laboratory animals [5, 6, 23], which importantly contributes to the age-related decline in NVC responses.”
BackgroundNeuronal and Vascular Oxidative Stress in Alzheimers Disease
A. Massaad, C. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376244 · Cited by 103
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.026 · Cited by 108
“In turn, genetic ablation of NOX2, one isoform of the catalytic subunit of NADPH oxidase, is able to counteract the oxidative stress and neurotoxicity in PD [219] and TBI,[220] and also the cerebrovascular dysfunction in aging [215] and AD [221].”
BackgroundUngvari, Z., Tarantini, S., Hertelendy, P., Valcarcel-Ares, M. N., Fülöp, G. A., Logan, S., Kiss, T., Farkas, E., Csiszar, A., & Yabluchanskiy, A. (2017) · GeroScience · doi:10.1007/s11357-017-9964-z · Cited by 101
“There is also strong experimental evidence that endothelial NO production contributes to glio-vascular coupling (Chen et al. 2014; Girouard et al. 2007; Longden and Nelson 2011; Ma et al. 1996; Stobart et al. 2013; Toth e t a l .”
BackgroundNOX Activity Is Increased in Mild Cognitive Impairment
Bruce-Keller, A. J., Gupta, S., Parrino, T. E., Knight, A. G., Ebenezer, P. J., Weidner, A. M., LeVine, H., Keller, J. N., & Markesbery, W. R. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2823 · Cited by 104
“Additional experiments confirmed the effects of apocynin by using specific decoy peptides (gp91ds-tat) that also specifically prevent the assembly of NADPH oxidase (48, 52) (data not shown).”
Progranulin Deficiency Promotes Post-Ischemic Blood–Brain Barrier Disruption
Jackman, K., Kahles, T., Lane, D., Garcia-Bonilla, L., Abe, T., Capone, C., Hochrainer, K., Voss, H., Zhou, P., Ding, A., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4318-13.2013 · Cited by 99
“Now that a role of PGRN in BBB structure and function has been established in young mice, in the absence of confounding effects of aging on the BBB (Zlokovic, 2008), CBF regulation (Park et al., 2007), and ischemic injury (Nagayama et al, 1999).”
BackgroundSelf-citationIn Pursuit of Healthy Aging: Effects of Nutrition on Brain Function
Melzer, T. M., Manosso, L. M., Yau, S.-Y., Gil-Mohapel, J., & Brocardo, P. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095026 · Cited by 83
“Nitric oxide (NO), a reactive nitrogen species (RNS) involved in neuronal signaling, has been linked to vascular dysfunction in the aging cerebral cortex when produced in excess [169].”
BackgroundEfficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury
Wu, H., Wu, T., Li, M., & Wang, J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.028 · Cited by 102
NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet
Pepping, J. K., Freeman, L. R., Gupta, S., Keller, J. N., & Bruce-Keller, A. J. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00398.2012 · Cited by 94
Toth, P., Tarantini, S., Davila, A., Valcarcel-Ares, M. N., Tucsek, Z., Varamini, B., Ballabh, P., Sonntag, W. E., Baur, J. A., Csiszar, A., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00463.2015 · Cited by 92
Tarantini, S., Fülöp, G., Kiss, T., Farkas, E., Zölei-Szénási, D., Galván, V., Tóth, P., Csiszár, A., Ungvari, Z. I., & Yabluchanskiy, A. (2017) · GeroScience · doi:10.1007/s11357-017-9980-z · Cited by 97
Csiszar, A., Tarantini, S., Fülöp, G. A., Kiss, T., Valcarcel-Ares, M. N., Galvan, V., Ungvari, Z., & Yabluchanskiy, A. (2017) · GeroScience · doi:10.1007/s11357-017-9991-9 · Cited by 93
Nox2 contributes to age-related oxidative damage to neurons and the cerebral vasculature
Fan, L. M., Geng, L., Cahill‐Smith, S., Liu, F., Douglas, G., McKenzie, C.-A., Smith, C., Brooks, G., Channon, K. M., & Li, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125173 · Cited by 94
Oxidative stress in cerebral small vessel disease. Role of reactive species
Grochowski, C., Litak, J., Kamieniak, P., & Maciejewski, R. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1402304 · Cited by 95
“Moreover, genetic mitochondrial SOD2, which is a source of mitochondria derived ROS, also worsens the neurobehavioral deficits in CAA angiopathy [97] and increases the parenchymal amyloid burden [98].”
BackgroundThe role of NOX inhibitors in neurodegenerative diseases
Barua, S., Kim, J. Y., Yenari, M. A., & Lee, J. E. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.07.1721 · Cited by 97
“Although NOX2ds-tat does not have any known test performed in stroke, it is known to inhibit oxidative stress that affects the cerebrovascular system (Park et al., 2007).”
BackgroundCsiszár, A., Csiszar, A., Pinto, J. T., Gautam, T., Kleusch, C., Hoffmann, B., Tucsek, Z., Toth, P., Sonntag, W. E., & Ungvari, Z. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu029 · Cited by 85
Zhang, Z., Song, Y., Zhang, Z., Li, D., Zhu, H., Liang, R., Gu, Y., Pang, Y., Qi, J., Wu, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655814 · Cited by 89
“We evaluated ROS after ICH by in situ detection of oxidized hydroethidine.(26,27) Hydroethidine (Molecular Probes, Eugene, OR) was dissolved in dimethyl sulfoxide (DMSO) and then diluted in phosphate-buffered saline to an end concentration of 1mg/mL.”
MethodThe early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85
“…in young animals the vascular dysfunction seems to be caused mainly by the effects of soluble Ab, the combinatorial effect of soluble Ab, CAA and age-dependent vascular alterations is probably responsible for the vascular impairments in older animals (Park et al., 2007, 2008; Han et al., 2008).”
BackgroundLourenço, C. F., & Laranjinha, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729201 · Cited by 85
“Park and coworkers demonstrated that the attenuation of the CBF changes to whisker stimulation, as observed in aged and AD mice, could be abrogated by both a SOD mimetic (MnTBAP) and a NOX inhibitor (peptide gp91ds-tat) (Park et al., 2007, 2008).”
BackgroundDuncombe, J., Lennen, R. J., Jansen, M. A., Marshall, I., Wardlaw, J. M., & Horsburgh, K. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12375 · Cited by 80
Dysfunction of Mouse Cerebral Arteries during Early Aging
Balbi, M., Ghosh, M., Longden, T. A., Vega, M. J., Gesierich, B., Hellal, F., Lourbopoulos, A., Nelson, M. T., & Plesnila, N. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.107 · Cited by 83
Lourenço, C. F., Ledo, A., Barbosa, R. M., & Laranjinha, J. A. N. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.01.013 · Cited by 90
“In support to this notion, converging evidence highlight oxidative stress as a pivotal early factor in neurovascular uncoupling in AD and agingmodels (Hamel et al., 2008; Park et al., 2007; Toth et al., 2014).”
Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging
Mladenov, M. I., Lubomirov, L. T., Grisk, O., Avtanski, D. B., Mitrokhin, V. M., Sazdova, I., Keremidarska‐Markova, M., Danailova, Y., Nikolaev, G., Konakchieva, R., et al. (2023) · Antioxidants · doi:10.3390/antiox12051126 · Cited by 89
“While the detrimental effect of ROS on cognition in relation to microcirculation is well documented [43,44], recently in animal models of cerebral artery occlusion and reperfusion, combating ROS accumulation using plant glycosides has also been shown to be able to restore cognition [45], pointing out the importance of…”
BackgroundLatimer, C. S., Searcy, J. L., Bridges, M. T., Brewer, L. D., Popović, J., Blalock, E. M., Landfield, P. W., Thibault, O., & Porter, N. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026812 · Cited by 80
“Given that astrocytes also mediate local cerebral blood flow [46], endothelin release from reactive astrocytes could potentially exacerbate preexisting age-related changes in blood flow [60].”
Nyúl-Tóth, Á., Tarantini, S., DelFavero, J., Yan, F., Balasubramanian, P., Yabluchanskiy, A., Ahire, C., Kiss, T., Csipo, T., Lipecz, A., et al. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00709.2020 · Cited by 75
Metadata
- Authors
- Park, L., Anrather, J., Girouard, H., Zhou, P., & Iadecola, C.
- Affiliations
- Cornell University (US)
- Division of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York, USA
- Corresponding author
- Iadecola, Costantino
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-12
- Volume
- 27
- Issue
- 12
- Pages
- 1908-1918
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2011190955
- Cited by
- 275
- References
- 42
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 15 · 2023: 15 · 2022: 16 · 2021: 19 · 2020: 20 · 2019: 20 · 2018: 13 · 2017: 16 · 2016: 20 · 2015: 15 · 2014: 18 · 2013: 12 · 2012: 14
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2r01ns038252-06, HL18974)
- National Heart, Lung, and Blood Institute (HL-18974, P01HL018974)
- National Institute of Neurological Disorders and Stroke (NS-38252)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NOX2, NADPH oxidase, reactive oxygen species, cerebral blood flow, cerebrovascular dysfunction, brain aging, oxidative stress, neurovascular regulation, superoxide, gp91phox, ischemic stroke, vascular cognitive impairment, acetylcholine, bradykinin, nitric oxide
- MeSH terms
- NADPH Oxidase 2, Aging, Animals, Cerebrovascular Disorders, Data Interpretation, Statistical, Endothelium, Vascular, Enzyme Inhibitors, Immunohistochemistry, Male, Membrane Glycoproteins, Metalloporphyrins, Mice, Inbred C57BL, Microcirculation, Receptors, Immunologic, Synapses, Free Radical Scavengers, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, NADPH Oxidases, Neocortex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.